Structure

Physi-Chem Properties

Molecular Weight:  595.24
Volume:  591.78
LogP:  3.342
LogD:  2.213
LogS:  -3.866
# Rotatable Bonds:  10
TPSA:  147.55
# H-Bond Aceptor:  11
# H-Bond Donor:  1
# Rings:  5
# Heavy Atoms:  11

MedChem Properties

QED Drug-Likeness Score:  0.387
Synthetic Accessibility Score:  5.721
Fsp3:  0.531
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.315
MDCK Permeability:  5.877068542758934e-05
Pgp-inhibitor:  1.0
Pgp-substrate:  0.001
Human Intestinal Absorption (HIA):  0.024
20% Bioavailability (F20%):  0.986
30% Bioavailability (F30%):  0.993

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.704
Plasma Protein Binding (PPB):  38.193260192871094%
Volume Distribution (VD):  1.6
Pgp-substrate:  29.336362838745117%

ADMET: Metabolism

CYP1A2-inhibitor:  0.167
CYP1A2-substrate:  0.054
CYP2C19-inhibitor:  0.052
CYP2C19-substrate:  0.074
CYP2C9-inhibitor:  0.099
CYP2C9-substrate:  0.028
CYP2D6-inhibitor:  0.56
CYP2D6-substrate:  0.057
CYP3A4-inhibitor:  0.766
CYP3A4-substrate:  0.451

ADMET: Excretion

Clearance (CL):  7.509
Half-life (T1/2):  0.572

ADMET: Toxicity

hERG Blockers:  0.576
Human Hepatotoxicity (H-HT):  0.89
Drug-inuced Liver Injury (DILI):  0.973
AMES Toxicity:  0.01
Rat Oral Acute Toxicity:  0.572
Maximum Recommended Daily Dose:  0.029
Skin Sensitization:  0.339
Carcinogencity:  0.124
Eye Corrosion:  0.003
Eye Irritation:  0.013
Respiratory Toxicity:  0.953

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC84815

Natural Product ID:  NPC84815
Common Name*:   GTTSSNILRZPHSK-RSCAUIJKSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  GTTSSNILRZPHSK-RSCAUIJKSA-N
Standard InCHI:  InChI=1S/C32H37NO10/c1-18(34)39-22-14-15-30(5,38)32-25(41-28(37)21-13-10-16-33-17-21)23(29(3,4)43-32)24(40-19(2)35)26(31(22,32)6)42-27(36)20-11-8-7-9-12-20/h7-13,16-17,22-26,38H,14-15H2,1-6H3/t22-,23+,24-,25+,26-,30-,31-,32-/m0/s1
SMILES:  CC(=O)O[C@H]1[C@@H]2[C@@H](OC(=O)c3cccnc3)[C@]3([C@@]([C@H]1OC(=O)c1ccccc1)(C)[C@H](CC[C@]3(C)O)OC(=O)C)OC2(C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1796138
PubChem CID:   44598212
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001550] Sesquiterpenoids
          • [CHEMONTID:0002051] Agarofurans

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15653 Celastrus vulcanicola Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[18616221]
NPO15653 Celastrus vulcanicola Species Celastraceae Eukaryota stems Montecristo National Park, province of Santa Ana, El Salvador 2004-JUN PMID[20873773]
NPO15653 Celastrus vulcanicola Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[21419633]
NPO15653 Celastrus vulcanicola Species Celastraceae Eukaryota n.a. n.a. n.a. PMID[25695368]
NPO15653 Celastrus vulcanicola Species Celastraceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT88 Organism Mycobacterium tuberculosis Mycobacterium tuberculosis MIC > 25.0 ug.mL-1 PMID[531487]
NPT790 Organism Mycobacterium tuberculosis H37Rv Mycobacterium tuberculosis H37Rv MIC > 25.0 ug.mL-1 PMID[531487]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC84815 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC301368
0.9897 High Similarity NPC6981
0.9848 High Similarity NPC127720
0.9848 High Similarity NPC127026
0.9846 High Similarity NPC294579
0.9846 High Similarity NPC144779
0.9798 High Similarity NPC471980
0.9795 High Similarity NPC471016
0.9794 High Similarity NPC4421
0.9749 High Similarity NPC328154
0.9745 High Similarity NPC62367
0.9744 High Similarity NPC470306
0.9695 High Similarity NPC216428
0.9694 High Similarity NPC471014
0.9694 High Similarity NPC475408
0.9652 High Similarity NPC87152
0.9652 High Similarity NPC228377
0.9652 High Similarity NPC122968
0.9652 High Similarity NPC476110
0.9652 High Similarity NPC475600
0.9652 High Similarity NPC475631
0.9652 High Similarity NPC328186
0.9652 High Similarity NPC477787
0.9645 High Similarity NPC75600
0.9645 High Similarity NPC473115
0.9645 High Similarity NPC6576
0.9645 High Similarity NPC158020
0.9645 High Similarity NPC473089
0.9645 High Similarity NPC212768
0.9643 High Similarity NPC477907
0.9643 High Similarity NPC42678
0.9643 High Similarity NPC477909
0.9604 High Similarity NPC471977
0.9604 High Similarity NPC470486
0.9604 High Similarity NPC475644
0.9604 High Similarity NPC471190
0.9598 High Similarity NPC477912
0.9554 High Similarity NPC211920
0.9552 High Similarity NPC477902
0.951 High Similarity NPC150698
0.951 High Similarity NPC292416
0.951 High Similarity NPC96801
0.951 High Similarity NPC473689
0.951 High Similarity NPC475596
0.951 High Similarity NPC316841
0.951 High Similarity NPC475303
0.9505 High Similarity NPC473506
0.9502 High Similarity NPC76565
0.9502 High Similarity NPC250807
0.9502 High Similarity NPC57797
0.949 High Similarity NPC472553
0.9463 High Similarity NPC320324
0.9463 High Similarity NPC319880
0.9463 High Similarity NPC30456
0.9463 High Similarity NPC244839
0.9458 High Similarity NPC124029
0.9455 High Similarity NPC475137
0.9455 High Similarity NPC475498
0.9455 High Similarity NPC473850
0.9453 High Similarity NPC477788
0.9417 High Similarity NPC237702
0.9409 High Similarity NPC148860
0.9403 High Similarity NPC477903
0.94 High Similarity NPC472555
0.9372 High Similarity NPC475406
0.9372 High Similarity NPC327769
0.9363 High Similarity NPC475601
0.9363 High Similarity NPC146824
0.9337 High Similarity NPC304179
0.9337 High Similarity NPC48042
0.9337 High Similarity NPC472550
0.9327 High Similarity NPC327904
0.9327 High Similarity NPC38959
0.9317 High Similarity NPC475362
0.93 High Similarity NPC206343
0.93 High Similarity NPC477908
0.9296 High Similarity NPC264674
0.9296 High Similarity NPC319128
0.9261 High Similarity NPC477911
0.925 High Similarity NPC477910
0.9227 High Similarity NPC477906
0.92 High Similarity NPC228331
0.9194 High Similarity NPC253482
0.9188 High Similarity NPC63041
0.9187 High Similarity NPC170751
0.9183 High Similarity NPC469748
0.9171 High Similarity NPC477900
0.9171 High Similarity NPC477899
0.9167 High Similarity NPC235364
0.9095 High Similarity NPC475426
0.9095 High Similarity NPC35208
0.9078 High Similarity NPC26881
0.9069 High Similarity NPC477901
0.9065 High Similarity NPC475648
0.8911 High Similarity NPC476467
0.8905 High Similarity NPC91125
0.881 High Similarity NPC14116
0.881 High Similarity NPC285411
0.8768 High Similarity NPC311196
0.8768 High Similarity NPC134384
0.8725 High Similarity NPC323551
0.8725 High Similarity NPC280473
0.8721 High Similarity NPC475533
0.8692 High Similarity NPC238278
0.8683 High Similarity NPC51008
0.8683 High Similarity NPC41724
0.8682 High Similarity NPC475315
0.8682 High Similarity NPC324619
0.8676 High Similarity NPC471013
0.8676 High Similarity NPC180668
0.8676 High Similarity NPC148896
0.8657 High Similarity NPC289086
0.8645 High Similarity NPC213143
0.8578 High Similarity NPC472752
0.8538 High Similarity NPC233727
0.8533 High Similarity NPC53255
0.8533 High Similarity NPC475301
0.8533 High Similarity NPC326930
0.8533 High Similarity NPC85879
0.852 High Similarity NPC10904
0.851 High Similarity NPC30570
0.8496 Intermediate Similarity NPC13603
0.8489 Intermediate Similarity NPC471015
0.8469 Intermediate Similarity NPC162812
0.8454 Intermediate Similarity NPC292517
0.8413 Intermediate Similarity NPC165837
0.8391 Intermediate Similarity NPC328928
0.839 Intermediate Similarity NPC475835
0.8384 Intermediate Similarity NPC473833
0.8341 Intermediate Similarity NPC187494
0.8333 Intermediate Similarity NPC62844
0.8333 Intermediate Similarity NPC193361
0.8317 Intermediate Similarity NPC470189
0.8317 Intermediate Similarity NPC40919
0.8312 Intermediate Similarity NPC471978
0.8276 Intermediate Similarity NPC470279
0.8261 Intermediate Similarity NPC470190
0.8259 Intermediate Similarity NPC476090
0.8255 Intermediate Similarity NPC319556
0.8205 Intermediate Similarity NPC471979
0.8164 Intermediate Similarity NPC309498
0.816 Intermediate Similarity NPC207531
0.8069 Intermediate Similarity NPC103230
0.7972 Intermediate Similarity NPC253314
0.7892 Intermediate Similarity NPC471004
0.785 Intermediate Similarity NPC111732
0.7826 Intermediate Similarity NPC320748
0.7826 Intermediate Similarity NPC324245
0.7799 Intermediate Similarity NPC32451
0.7799 Intermediate Similarity NPC328559
0.7751 Intermediate Similarity NPC79223
0.7692 Intermediate Similarity NPC329024
0.7652 Intermediate Similarity NPC37473
0.7617 Intermediate Similarity NPC156044
0.761 Intermediate Similarity NPC44354
0.7591 Intermediate Similarity NPC141385
0.7571 Intermediate Similarity NPC59033
0.7571 Intermediate Similarity NPC317672
0.7525 Intermediate Similarity NPC317010
0.7523 Intermediate Similarity NPC25442
0.7523 Intermediate Similarity NPC12944
0.7465 Intermediate Similarity NPC155792
0.7444 Intermediate Similarity NPC140311
0.7438 Intermediate Similarity NPC471997
0.7419 Intermediate Similarity NPC470280
0.7378 Intermediate Similarity NPC106593
0.7373 Intermediate Similarity NPC107123
0.7345 Intermediate Similarity NPC473667
0.732 Intermediate Similarity NPC107287
0.7316 Intermediate Similarity NPC70155
0.7311 Intermediate Similarity NPC109922
0.729 Intermediate Similarity NPC160127
0.729 Intermediate Similarity NPC50997
0.728 Intermediate Similarity NPC476516
0.7273 Intermediate Similarity NPC314834
0.7273 Intermediate Similarity NPC327699
0.7269 Intermediate Similarity NPC475223
0.7264 Intermediate Similarity NPC198205
0.7264 Intermediate Similarity NPC21483
0.7264 Intermediate Similarity NPC146724
0.7264 Intermediate Similarity NPC135950
0.7252 Intermediate Similarity NPC317752
0.725 Intermediate Similarity NPC183537
0.7246 Intermediate Similarity NPC207851
0.7235 Intermediate Similarity NPC246983
0.7235 Intermediate Similarity NPC475448
0.7228 Intermediate Similarity NPC249614
0.7225 Intermediate Similarity NPC325775
0.7225 Intermediate Similarity NPC328798
0.722 Intermediate Similarity NPC164340
0.7215 Intermediate Similarity NPC15406
0.7209 Intermediate Similarity NPC123395
0.7209 Intermediate Similarity NPC103361
0.7207 Intermediate Similarity NPC318299
0.7203 Intermediate Similarity NPC210296
0.72 Intermediate Similarity NPC253738
0.72 Intermediate Similarity NPC477975
0.7198 Intermediate Similarity NPC327373
0.7198 Intermediate Similarity NPC233334
0.7196 Intermediate Similarity NPC198390

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC84815 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8304 Intermediate Similarity NPD8468 Phase 2
0.8196 Intermediate Similarity NPD8304 Clinical (unspecified phase)
0.7943 Intermediate Similarity NPD7396 Approved
0.7767 Intermediate Similarity NPD5975 Clinical (unspecified phase)
0.7639 Intermediate Similarity NPD7927 Clinical (unspecified phase)
0.7569 Intermediate Similarity NPD3794 Approved
0.7569 Intermediate Similarity NPD3795 Approved
0.7474 Intermediate Similarity NPD820 Phase 3
0.7403 Intermediate Similarity NPD5891 Approved
0.7349 Intermediate Similarity NPD5721 Clinical (unspecified phase)
0.7327 Intermediate Similarity NPD7010 Phase 3
0.7323 Intermediate Similarity NPD6635 Approved
0.7319 Intermediate Similarity NPD1483 Discontinued
0.729 Intermediate Similarity NPD6661 Clinical (unspecified phase)
0.7285 Intermediate Similarity NPD7069 Discontinued
0.7273 Intermediate Similarity NPD7234 Approved
0.7273 Intermediate Similarity NPD7233 Approved
0.7227 Intermediate Similarity NPD6529 Discontinued
0.7212 Intermediate Similarity NPD3280 Approved
0.7202 Intermediate Similarity NPD3947 Discontinued
0.7188 Intermediate Similarity NPD3389 Approved
0.7188 Intermediate Similarity NPD3393 Approved
0.7188 Intermediate Similarity NPD3394 Approved
0.7182 Intermediate Similarity NPD2509 Approved
0.7182 Intermediate Similarity NPD2510 Approved
0.7171 Intermediate Similarity NPD5751 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD4417 Approved
0.7161 Intermediate Similarity NPD7885 Phase 2
0.7161 Intermediate Similarity NPD7886 Phase 2
0.7156 Intermediate Similarity NPD8326 Phase 3
0.7156 Intermediate Similarity NPD8327 Clinical (unspecified phase)
0.7156 Intermediate Similarity NPD8325 Phase 3
0.7143 Intermediate Similarity NPD485 Clinical (unspecified phase)
0.7123 Intermediate Similarity NPD6987 Phase 1
0.7113 Intermediate Similarity NPD9271 Approved
0.7078 Intermediate Similarity NPD2121 Clinical (unspecified phase)
0.7072 Intermediate Similarity NPD4506 Discontinued
0.7045 Intermediate Similarity NPD7708 Approved
0.7037 Intermediate Similarity NPD8485 Approved
0.7031 Intermediate Similarity NPD4301 Approved
0.7018 Intermediate Similarity NPD6770 Approved
0.7009 Intermediate Similarity NPD5475 Discontinued
0.7005 Intermediate Similarity NPD53 Approved
0.7005 Intermediate Similarity NPD4987 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD7778 Approved
0.7005 Intermediate Similarity NPD7777 Approved
0.7 Intermediate Similarity NPD7803 Approved
0.6995 Remote Similarity NPD8063 Discontinued
0.6987 Remote Similarity NPD8479 Phase 2
0.6985 Remote Similarity NPD6026 Approved
0.6981 Remote Similarity NPD6791 Phase 2
0.698 Remote Similarity NPD5088 Discontinued
0.6978 Remote Similarity NPD6657 Clinical (unspecified phase)
0.6974 Remote Similarity NPD7878 Phase 2
0.6968 Remote Similarity NPD6323 Clinical (unspecified phase)
0.6968 Remote Similarity NPD2831 Approved
0.6966 Remote Similarity NPD5801 Clinical (unspecified phase)
0.6963 Remote Similarity NPD2336 Approved
0.6955 Remote Similarity NPD6477 Clinical (unspecified phase)
0.6941 Remote Similarity NPD8486 Clinical (unspecified phase)
0.6935 Remote Similarity NPD7955 Approved
0.6935 Remote Similarity NPD7956 Approved
0.693 Remote Similarity NPD4376 Phase 3
0.693 Remote Similarity NPD4989 Phase 2
0.6926 Remote Similarity NPD6525 Clinical (unspecified phase)
0.6923 Remote Similarity NPD9074 Approved
0.6923 Remote Similarity NPD9075 Approved
0.6916 Remote Similarity NPD8435 Approved
0.6916 Remote Similarity NPD8361 Approved
0.6916 Remote Similarity NPD8360 Approved
0.6898 Remote Similarity NPD6361 Phase 2
0.6878 Remote Similarity NPD7187 Phase 2
0.6866 Remote Similarity NPD4427 Phase 2
0.6846 Remote Similarity NPD7417 Discontinued
0.6842 Remote Similarity NPD7707 Approved
0.6842 Remote Similarity NPD6642 Approved
0.6842 Remote Similarity NPD6641 Approved
0.6835 Remote Similarity NPD2307 Discontinued
0.6835 Remote Similarity NPD7061 Clinical (unspecified phase)
0.6822 Remote Similarity NPD6257 Clinical (unspecified phase)
0.6822 Remote Similarity NPD4948 Discontinued
0.6822 Remote Similarity NPD8052 Clinical (unspecified phase)
0.6822 Remote Similarity NPD8424 Clinical (unspecified phase)
0.6816 Remote Similarity NPD5901 Discontinued
0.6804 Remote Similarity NPD107 Approved
0.68 Remote Similarity NPD7947 Clinical (unspecified phase)
0.6798 Remote Similarity NPD2511 Approved
0.6797 Remote Similarity NPD7404 Approved
0.6786 Remote Similarity NPD6732 Clinical (unspecified phase)
0.6786 Remote Similarity NPD4862 Clinical (unspecified phase)
0.6784 Remote Similarity NPD7470 Discontinued
0.6783 Remote Similarity NPD8000 Clinical (unspecified phase)
0.6769 Remote Similarity NPD8112 Clinical (unspecified phase)
0.6766 Remote Similarity NPD8289 Discontinued
0.6762 Remote Similarity NPD8470 Clinical (unspecified phase)
0.676 Remote Similarity NPD8091 Phase 3
0.6759 Remote Similarity NPD6281 Approved
0.6756 Remote Similarity NPD7562 Approved
0.6754 Remote Similarity NPD5866 Approved
0.6753 Remote Similarity NPD7395 Discontinued
0.6749 Remote Similarity NPD8412 Phase 1
0.6746 Remote Similarity NPD7862 Clinical (unspecified phase)
0.6745 Remote Similarity NPD7414 Clinical (unspecified phase)
0.674 Remote Similarity NPD7998 Clinical (unspecified phase)
0.6739 Remote Similarity NPD5490 Discontinued
0.6729 Remote Similarity NPD4889 Approved
0.6723 Remote Similarity NPD6962 Phase 2
0.6722 Remote Similarity NPD8409 Suspended
0.6712 Remote Similarity NPD8248 Clinical (unspecified phase)
0.6712 Remote Similarity NPD4396 Clinical (unspecified phase)
0.6711 Remote Similarity NPD7957 Phase 1
0.6711 Remote Similarity NPD7958 Clinical (unspecified phase)
0.6711 Remote Similarity NPD4901 Clinical (unspecified phase)
0.6709 Remote Similarity NPD8356 Approved
0.6708 Remote Similarity NPD6790 Phase 1
0.6701 Remote Similarity NPD2896 Discontinued
0.6694 Remote Similarity NPD7967 Discontinued
0.6682 Remote Similarity NPD6226 Phase 3
0.6681 Remote Similarity NPD5022 Discontinued
0.668 Remote Similarity NPD8350 Clinical (unspecified phase)
0.668 Remote Similarity NPD3006 Discontinued
0.6667 Remote Similarity NPD4529 Approved
0.6667 Remote Similarity NPD6298 Discontinued
0.6667 Remote Similarity NPD4528 Approved
0.6667 Remote Similarity NPD6446 Discontinued
0.6667 Remote Similarity NPD6262 Clinical (unspecified phase)
0.6667 Remote Similarity NPD8020 Approved
0.6667 Remote Similarity NPD4900 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4526 Approved
0.6667 Remote Similarity NPD8021 Approved
0.6653 Remote Similarity NPD8372 Clinical (unspecified phase)
0.6653 Remote Similarity NPD3925 Approved
0.6653 Remote Similarity NPD7688 Phase 1
0.6653 Remote Similarity NPD5805 Approved
0.6653 Remote Similarity NPD5482 Discontinued
0.6652 Remote Similarity NPD5003 Discontinued
0.6652 Remote Similarity NPD7571 Clinical (unspecified phase)
0.6652 Remote Similarity NPD7191 Phase 2
0.6639 Remote Similarity NPD7807 Clinical (unspecified phase)
0.6638 Remote Similarity NPD3326 Clinical (unspecified phase)
0.6638 Remote Similarity NPD6995 Phase 1
0.6637 Remote Similarity NPD4600 Approved
0.6637 Remote Similarity NPD6479 Discontinued
0.6637 Remote Similarity NPD4601 Approved
0.6628 Remote Similarity NPD8467 Approved
0.6628 Remote Similarity NPD8466 Approved
0.6628 Remote Similarity NPD8465 Approved
0.6624 Remote Similarity NPD5640 Discontinued
0.6624 Remote Similarity NPD7426 Phase 1
0.6622 Remote Similarity NPD6176 Phase 1
0.6621 Remote Similarity NPD6665 Discontinued
0.6621 Remote Similarity NPD3924 Approved
0.6621 Remote Similarity NPD3923 Approved
0.6621 Remote Similarity NPD3922 Approved
0.6621 Remote Similarity NPD3921 Approved
0.6618 Remote Similarity NPD2582 Approved
0.6618 Remote Similarity NPD2581 Approved
0.6612 Remote Similarity NPD6716 Phase 1
0.6609 Remote Similarity NPD1926 Approved
0.6608 Remote Similarity NPD5429 Discontinued
0.6608 Remote Similarity NPD3371 Approved
0.66 Remote Similarity NPD1270 Approved
0.6598 Remote Similarity NPD4373 Phase 2
0.6597 Remote Similarity NPD7268 Clinical (unspecified phase)
0.6597 Remote Similarity NPD8430 Approved
0.6589 Remote Similarity NPD8363 Approved
0.6589 Remote Similarity NPD3178 Discontinued
0.6589 Remote Similarity NPD8364 Approved
0.6582 Remote Similarity NPD7269 Clinical (unspecified phase)
0.6581 Remote Similarity NPD6955 Clinical (unspecified phase)
0.6579 Remote Similarity NPD7467 Discontinued
0.6574 Remote Similarity NPD7424 Clinical (unspecified phase)
0.6574 Remote Similarity NPD6241 Phase 1
0.6574 Remote Similarity NPD8407 Phase 2
0.6573 Remote Similarity NPD6276 Discontinued
0.6573 Remote Similarity NPD5398 Clinical (unspecified phase)
0.6571 Remote Similarity NPD7576 Discontinued
0.657 Remote Similarity NPD1631 Approved
0.6564 Remote Similarity NPD7001 Phase 3
0.6561 Remote Similarity NPD7944 Discontinued
0.6559 Remote Similarity NPD5483 Clinical (unspecified phase)
0.6553 Remote Similarity NPD1996 Discontinued
0.6552 Remote Similarity NPD5417 Clinical (unspecified phase)
0.6544 Remote Similarity NPD4375 Approved
0.6538 Remote Similarity NPD8365 Clinical (unspecified phase)
0.6538 Remote Similarity NPD3354 Phase 2
0.6537 Remote Similarity NPD3815 Phase 1
0.6537 Remote Similarity NPD3816 Phase 1
0.6533 Remote Similarity NPD3813 Approved
0.6529 Remote Similarity NPD6494 Phase 2
0.6528 Remote Similarity NPD8425 Approved
0.6528 Remote Similarity NPD8459 Approved
0.6528 Remote Similarity NPD8426 Approved
0.6528 Remote Similarity NPD8460 Approved
0.6527 Remote Similarity NPD6553 Clinical (unspecified phase)
0.6527 Remote Similarity NPD6292 Clinical (unspecified phase)
0.6525 Remote Similarity NPD5147 Discontinued
0.6525 Remote Similarity NPD4923 Phase 1
0.6522 Remote Similarity NPD6204 Clinical (unspecified phase)
0.652 Remote Similarity NPD8101 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data